SEC Company Response from Vaxart, Inc. (VXRT) (CIK 0000072444) (VXRT) — Apr 8, 2019
Vaxart, Inc. (VXRT) (CIK 0000072444)
Date: April 8, 2019 · CIK: 0000072444 · Accession: 0001104659-19-020255
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-229536
Letter
April 8, 2019
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn:
Donald Field
Re:
Vaxart, Inc.
Registration Statement on Form S-1
290 Utah Ave, Suite 200
South San Francisco, CA 94080
File No. 333-229536
Acceleration Request
Requested Date: April 8, 2019
Requested Time: 5:00 PM Eastern Daylight Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-229536) (the “Registration Statement”) to become effective on April 8, 2019 at 5:00 p.m. Eastern Daylight Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of John McKenna and Josh Seidenfeld of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with John McKenna of Cooley LLP, counsel to the Registrant, at (650) 843-5059, or in his absence, Josh Seidenfeld at (650) 843-5862.
Very truly yours,
Vaxart, Inc.
Show Raw Text
CORRESP 1 filename1.htm April 8, 2019 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Donald Field Re: Vaxart, Inc. Registration Statement on Form S-1 290 Utah Ave, Suite 200 South San Francisco, CA 94080 File No. 333-229536 Acceleration Request Requested Date: April 8, 2019 Requested Time: 5:00 PM Eastern Daylight Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-229536) (the “Registration Statement”) to become effective on April 8, 2019 at 5:00 p.m. Eastern Daylight Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of John McKenna and Josh Seidenfeld of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with John McKenna of Cooley LLP, counsel to the Registrant, at (650) 843-5059, or in his absence, Josh Seidenfeld at (650) 843-5862. Very truly yours, Vaxart, Inc. By: /s/ Wouter W. Latour, M.D. Name: Wouter W. Latour, M.D. Title: Chief Executive Officer cc: John T. McKenna, Cooley LLP Josh Seidenfeld, Cooley LLP Gary Emmanuel, McDermott Will & Emery LLP Heidi Steele, McDermott Will & Emery LLP